Hellerup, G7CIK 13883254 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
24 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Brookfield Corp | 3.50M | $160.44M | 12.5% | +1.17M | Added |
| 2 | Edgewise Therapeutics Inc | 5.35M | $132.76M | 10.3% | 0 | Held |
| 3 | Asml Holding N V | 113.9K | $121.91M | 9.5% | −31.9K | Reduced |
| 4 | Mirum Pharmaceuticals Inc |
| 1.26M |
| $99.85M |
| 7.8% |
| 0 |
| Held |
| 5 | Salesforce Inc | 330.2K | $87.47M | 6.8% | 0 | Held |
| 6 | Crinetics Pharmaceuticals In | 1.63M | $75.64M | 5.9% | 0 | Held |
| 7 | Viridian Therapeutics Inc | 2.38M | $74.07M | 5.8% | 0 | Held |
| 8 | Maplight Therapeutics Inc | 3.69M | $64.76M | 5.0% | +3.69M | New |
| 9 | Zenas Biopharma Inc | 1.45M | $52.65M | 4.1% | −550.0K | Reduced |
| 10 | Pharvaris N V | 1.75M | $48.56M | 3.8% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio